Johnson & Johnson cuts price of TB drug in poorer countries

A Johnson & Johnson building is shown in Irvine, California.

NEW BRUNSWICK, New Jersey: Johnson & Johnson said on Monday (Jul 6) it was slashing the price of its version of tuberculosis drug bedaquiline to US$340 from US$400, for a six-month treatment, in low- and middle-income countries, to scale up its use during the COVID-19 pandemic.

J&J’s bedaquiline, marketed under the brand name Sirturo, will be available at the reduced price to more than 135 eligible countries, through the United Nations-hosted Stop TB Partnership’s Global Drug Facility, created in 2001 to negotiate lower prices for treatments.

The move comes at a time when the virus outbreak has been feared to have derailed global efforts to curtail the spread of tuberculosis, a bacterial infection that mainly affects a patient’s lungs.

Between 2020 and 2025 an additional 1.4 million TB deaths could be registered as a direct consequence of the pandemic, the World Health Organization said in May.

J&J said it would offer an increasing percentage of free drugs when certain volume thresholds are reached annually, to help support the further scaling up of all-oral treatment combinations, the use of which has been recommended by the WHO in light of the pandemic.

In the first year, the initiative could lead to an estimated savings of up to US$16 million for national TB programmes, the drugmaker and Stop TB Partnership said.

New treatments against tuberculosis have been sparse, with not-for-profit TB Alliance’s pretomanid becoming only the third new medicine for drug-resistant tuberculosis to be approved in about 40 years, after J&J’s bedaquiline and Otsuka Pharmaceutical Co Ltd’s delamanid.

International aid group Médecins Sans Frontières, which has been demanding that J&J lower its price tag for bedaquiline to no more than US$1 per day, said the new price of about US$1.50 per day should be cut further and extended to more countries.

Z24 News

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

US health official Fauci says COVID-19 outbreak is 'serious situation'

Mon Jul 6 , 2020
NEW YORK: US health official Anthony Fauci said on Monday (Jul 6) that the current state of the COVID-19 outbreak in the United States “is really not good” and a “serious situation that we have to address immediately.” The United States is still “knee-deep” in the first wave of the […]

Share

Social menu is not set. You need to create menu and assign it to Social Menu on Menu Settings.